RecruitingPhase 4NCT07436156
SUMMIT RISE Study of Acute Ischemic Stroke Patients
SUMMIT RISE Study of Acute Ischemic Stroke Patients Evaluating the Route 92 Medical Reperfusion Systems.
Sponsor
Route 92 Medical, Inc.
Enrollment
500 participants
Start Date
Feb 12, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
SUMMIT RISE Study of Acute Ischemic Stroke Patients
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Acute ischemic stroke patient initially treated (first pass) with a Route 92 Medical Reperfusion System
- Informed consent completed and documented within 72 hours following thrombectomy procedure
- Endovascular treatment initiated (defined as time of groin puncture) within 8 hours from time last known well
- Age ≥ 18 years
Exclusion Criteria1
- None
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICERoute 92 Medical Reperfusion Systems
Mechanical thrombectomy with the Route 92 Medical Reperfusion Systems
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07436156
Related Trials
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
NCT0568664228 locations
Radial Versus Femoral Access For Thrombectomy in Patients With Acute Basilar Artery Occlusion
NCT059035601 location
A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well
NCT07361302224 locations
Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke
NCT064407073 locations
Endovascular Therapy Versus Best Medical Treatment for Acute Large Vessel Occlusion Stroke With Low NIHSS
NCT061434881 location